Cinemark Holdings Inc (NYSE:CNK – Get Free Report) EVP Melissa Thomas sold 7,944 shares of Cinemark stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $26.05, for a total value of $206,941.20. Following the transaction, the executive vice president directly owned 159,416 shares in the company, valued at approximately $4,152,786.80. The trade was a 4.75% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Melissa Thomas also recently made the following trade(s):
- On Wednesday, December 10th, Melissa Thomas sold 22,082 shares of Cinemark stock. The stock was sold at an average price of $24.81, for a total value of $547,854.42.
Cinemark Price Performance
Shares of CNK stock traded up $0.13 on Friday, reaching $25.50. The company’s stock had a trading volume of 60,719 shares, compared to its average volume of 2,690,929. The company has a market capitalization of $3.00 billion, a price-to-earnings ratio of 24.40, a price-to-earnings-growth ratio of 2.49 and a beta of 1.13. The stock’s fifty day simple moving average is $23.73 and its 200-day simple moving average is $26.07. The company has a current ratio of 0.76, a quick ratio of 0.72 and a debt-to-equity ratio of 5.01. Cinemark Holdings Inc has a 1 year low of $21.60 and a 1 year high of $34.01.
Analyst Upgrades and Downgrades
CNK has been the topic of a number of research reports. Moffett Nathanson raised shares of Cinemark from a “neutral” rating to a “buy” rating and set a $30.00 target price on the stock in a research report on Tuesday, January 20th. JPMorgan Chase & Co. decreased their price objective on Cinemark from $37.00 to $31.00 and set an “overweight” rating for the company in a research note on Thursday, January 22nd. Macquarie cut their target price on Cinemark from $36.00 to $34.00 and set an “outperform” rating on the stock in a research note on Thursday, January 15th. Barrington Research decreased their price target on shares of Cinemark from $36.00 to $32.00 and set an “outperform” rating for the company in a research report on Monday, January 26th. Finally, UBS Group raised Cinemark to a “buy” rating in a research report on Tuesday, January 20th. Ten analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $32.83.
Check Out Our Latest Stock Report on CNK
Hedge Funds Weigh In On Cinemark
Several large investors have recently made changes to their positions in the company. Marshall Wace LLP boosted its position in Cinemark by 758.9% during the second quarter. Marshall Wace LLP now owns 4,497,305 shares of the company’s stock worth $135,729,000 after purchasing an additional 3,973,689 shares in the last quarter. Squarepoint Ops LLC lifted its position in shares of Cinemark by 119.9% during the 2nd quarter. Squarepoint Ops LLC now owns 2,180,513 shares of the company’s stock valued at $65,808,000 after buying an additional 1,188,709 shares in the last quarter. Qube Research & Technologies Ltd grew its stake in Cinemark by 2.8% in the 3rd quarter. Qube Research & Technologies Ltd now owns 2,069,188 shares of the company’s stock valued at $57,979,000 after acquiring an additional 56,275 shares during the period. Cartenna Capital LP grew its stake in Cinemark by 29.4% in the 3rd quarter. Cartenna Capital LP now owns 1,650,000 shares of the company’s stock valued at $46,233,000 after acquiring an additional 375,000 shares during the period. Finally, Jain Global LLC increased its holdings in Cinemark by 37.4% in the 3rd quarter. Jain Global LLC now owns 1,644,623 shares of the company’s stock worth $46,082,000 after acquiring an additional 447,468 shares in the last quarter.
Cinemark Company Profile
Cinemark Holdings, Inc (NYSE: CNK) is a leading theatrical exhibitor that acquires, develops and operates motion picture theatres under the Cinemark® brand in the United States and Latin America. The company’s core business involves the presentation of first-run feature films coupled with an array of in‐theatre services, including concessions, premium auditoriums and loyalty programs. Cinemark’s exhibition portfolio encompasses both corporate‐owned and franchised complexes, offering moviegoers a range of experiences from standard screens to large‐format halls.
The company’s product offerings extend beyond ticket sales to include an assortment of concession items, such as popcorn, fountain beverages, candy and specialty snacks, as well as bar and lounge concepts in select locations.
Featured Stories
- Five stocks we like better than Cinemark
- Trade this between 9:30 and 10:45 am EST
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- When to buy gold (mathematically)
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Cinemark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cinemark and related companies with MarketBeat.com's FREE daily email newsletter.
